VIEW
IN BROWSER
EDITOR'S
NOTE: Big4Bio newsletters will not be
published from Dec 16, 2025, to Jan 4, 2026; they
will resume distribution on Monday, Jan 5, 2026.
|
|
| DECEMber
15, 2025 |
| Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
|
* may need subscription to view |
- Anixa Biosciences: Transfer of IND for
Breast Cancer Vaccine From Cleveland Clinic More
- Cytokinetics: Positive CHMP Opinion of
MYQORZO (Aficamten) for the Treatment of
Obstructive Hypertrophic Cardiomyopathy More
- FibroGen: Roxadustat Granted Orphan Drug
Designation for the Treatment of
Myelodysplastic Syndromes by the U.S. Food and
Drug Administration More
- Gilead: Investigational Single-Tablet
Regimen of Bictegravir and Lenacapavir for HIV
Treatment Meets Primary Endpoint in Phase 3
ARTISTRY-2 Trial More
- Immusoft: Secures FDA Orphan Drug
Designation for ISP-002 in MPS II, a
Progressive Lysosomal Storage Disease More
- Kyverna Therapeutics: Positive Topline Data
From Registrational KYSA-8 Trial of Miv-cel
(KYV-101) in Stiff Person Syndrome More
- Orca Bio: Orca-T Phase 3 Data Published in
Blood Demonstrate Significant Improvement in
Survival Free from Chronic Graft versus Host
Disease in Patients With Hematological
Malignancies More
- Profusa: U.S. Study Met Primary End Points
as Presented at Late Breaking Clinical Trials
at Paris Vascular Insights 2025 More
- Quince Therapeutics: Last Patient Last Visit
in Phase 3 NEAT Clinical Trial in Patients
With Ataxia-Telangiectasia More
- Spruce Biosciences: Appoints Proven
Pharmaceutical Commercial Leader Keli Walbert
to Board of Directors More
|
|
|
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- Chai Discovery: $130 Million Series B to
Transform Molecular Discovery More
More*
More*
- Dren Bio: Expands Strategic Collaboration
With Sanofi to Develop Next-Generation
B-Cell Depletion Therapy More
More
More*
- Exclusive VC Funding Data from BYTE51,
with Special Big4Bio Pricing More
- 4DMT: New Employment Inducement Grants More
- Jade Biosciences: $45 Million Private
Placement More
- JPM
Week Conference Readiness Packages (Big4Bio
Subscriber Discount) More
- Link Cell Therapies: Launches With Vision
of Advancing CAR-T Therapies in Solid and
Liquid Tumors More
|
|
|
|
| San
Francisco's most flexible contract
vivarium lab space: Start with a
few cages and grow. |
|
Learn More
→ |
|
|
- More
on Arcus Discontinuing Gilead-Partnered TIGIT
Trials Due to Futility More
More*
- Stanford: New Center Bridges Neuroscience
and Data Science to Decode the Brain More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The Big4Bio Podcast: Every Moment
Matters: Integrating AI into Drug Discovery
Podcast
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: SFBay Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
|
|
|
|
Feature your company |
| Apply
to have your company
showcased by Big4Bio |
|
|
|
|
|
|
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- M&A in Life Sciences: The Turning
Tide – Why Now is a Strategic Inflection for
Biopharma and Biotech More
- ICYMI: CEO’s Perspective: Big Moves Come
with Big Responsibility More
- ICYMI: CEO’s Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- ICYMI: The Power of Peer Learning - Why Even
Top Biotech Leaders Need Mentorship More
- ICYMI: What’s Next in Precision Medicine:
Leadership Challenges and Opportunities More
- The Rise of Fractional Talent in Life
Sciences: What to Expect in 2026 More
|
|
|
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:SFBay,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|